期刊
CELL
卷 161, 期 2, 页码 201-204出版社
CELL PRESS
DOI: 10.1016/j.cell.2015.03.037
关键词
-
资金
- Cancer Research Institute
- Melanoma Research Alliance
- Ovarian Cancer Research Fund
Although cancer immunotherapy can lead to durable outcomes, the percentage of patients who respond to this disruptive approach remains modest to date. Encouragingly, nanotechnology can enhance the efficacy of immunostimulatory small molecules and biologics by altering their co-localization, biodistribution, and release kinetics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据